3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
10
Breast Neoplasms
5
Pain
4
Agnosia
3
Rectal Neoplasms
2
Lung Neoplasms
2
Leiomyoma
2
Colonic Neoplasms
2
post laminectomy syndrome
1
Uterine Cervical Dysplasia
1
Upper Abdominal Cancer Surgery
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroma
1
Neuralgia
1
Neoplasms
1
Myoma
1
Lymphedema
1
Kidney Neoplasms
1
Intestinal Diseases
1
Inflammatory Bowel Diseases
1
Ileus
1
Hot Flashes
1
Hemorrhage
1
Head and Neck Neoplasms
1
Gynecologic Surgical Procedures
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Failed Back Surgery Syndrome
1
Diverticulosis, Colonic
1
Interventions
Capecitabine
13
Fluorouracil
11
Oxaliplatin
10
Bevacizumab
9
Leucovorin
6
Irinotecan
6
HMPL-013
4
Folfox protocol
4
Cetuximab
4
ferric carboxymaltose
3
regorafenib
2
gadolinium ethoxybenzyl DTPA
2
gadobenic acid
2
Triamcinolone
2
Standard of Care
2
Sodium Chloride
2
Radiofrequency Ablation
2
Pirinitramide
2
Morphine
2
Esomeprazole
2
Analgesia, Epidural
2
zidovudine 5'-monophosphate-mannose-albumin conjugate
1
sodium phosphate
1
raltitrexed
1
polyethylene glycol 3350
1
iron isomaltoside 1000
1
galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20
1
gadoteridol
1
gadoterate meglumine
1
gadodiamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Colorectal Neoplasms
×
Bupivacaine
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts